132 related articles for article (PubMed ID: 32773246)
1. Clinical characteristics and outcomes of patients with hepatic veno-occlusive disease induced by Gynura segetum: A retrospective study.
Feng MX; Shen Y; Lu YQ
J Integr Med; 2020 Sep; 18(5):434-440. PubMed ID: 32773246
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study.
Wang Y; Qiao D; Li Y; Xu F
BMC Gastroenterol; 2018 Oct; 18(1):156. PubMed ID: 30367628
[TBL] [Abstract][Full Text] [Related]
3. Hepatic veno-occlusive disease related to Gynura segetum: A case report.
Sun Z; Kang J; Zhang Y
Medicine (Baltimore); 2018 Apr; 97(17):e0552. PubMed ID: 29703039
[TBL] [Abstract][Full Text] [Related]
4. Gynura Segetum Related Hepatic Sinusoidal Obstruction Syndrome: A Liver Disease with High Mortality and Misdiagnosis Rate.
Ou P; Liu X; Tang Z; Hou Z; Liu L; Liu J; Zhou S; Fang Z; Sun K; Chen Y; Chen X; Li Y; Chen J
Curr Pharm Des; 2019; 25(35):3762-3768. PubMed ID: 31589115
[TBL] [Abstract][Full Text] [Related]
5. [Hematologic toxicity of Gynura segetum and effects on vascular endothelium in a rat model of hepatic veno-occlusive disease].
Fang J; Zhang G; Teng X; Zhang Z; Pan J; Shou Q; Chen M
Zhonghua Gan Zang Bing Za Zhi; 2015 Jan; 23(1):59-63. PubMed ID: 25751389
[TBL] [Abstract][Full Text] [Related]
6. Effect of ligustrazine on mice model of hepatic veno-occlusive disease induced by Gynura segetum.
Chen Z; Huo JR; Yang L; Zhu HY
J Gastroenterol Hepatol; 2011 Jun; 26(6):1016-21. PubMed ID: 21251065
[TBL] [Abstract][Full Text] [Related]
7. Expression of MMP-9 in hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Yu XZ; Ji T; Bai XL; Liang L; Wang LY; Chen W; Liang TB
J Zhejiang Univ Sci B; 2013 Jan; 14(1):68-75. PubMed ID: 23303633
[TBL] [Abstract][Full Text] [Related]
8. Hepatic veno-occlusive disease induced by Gymura segetum: report of two cases.
Dai HF; Gao Y; Yang M; Yu CH; Gu ZY; Chen WX
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):406-8. PubMed ID: 16911940
[TBL] [Abstract][Full Text] [Related]
9. Gynura root induces hepatic veno-occlusive disease: a case report and review of the literature.
Dai N; Yu YC; Ren TH; Wu JG; Jiang Y; Shen LG; Zhang J
World J Gastroenterol; 2007 Mar; 13(10):1628-31. PubMed ID: 17461462
[TBL] [Abstract][Full Text] [Related]
10. The effect of Salvia miltiorrhiza in a mouse model of hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Yang L; Huo JR; Zhu HY; Chen Z; Wang XY
Rev Esp Enferm Dig; 2019 Nov; 111(11):823-827. PubMed ID: 31566407
[TBL] [Abstract][Full Text] [Related]
11. [Clinical condition evaluation of hepatic veno-occlusive disease induced by gynura segetum].
Wu XJ; Yu MY; Yan YW
Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):635-6. PubMed ID: 24163873
[No Abstract] [Full Text] [Related]
12. Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Yao J; Wu J; Jia S; Shao J; Zhang X; Xu Z; Zhang H; Li H; Yao X
J Clin Lab Anal; 2022 Dec; 36(12):e24793. PubMed ID: 36447383
[TBL] [Abstract][Full Text] [Related]
13. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.
Lin G; Wang JY; Li N; Li M; Gao H; Ji Y; Zhang F; Wang H; Zhou Y; Ye Y; Xu HX; Zheng J
J Hepatol; 2011 Apr; 54(4):666-73. PubMed ID: 21146894
[TBL] [Abstract][Full Text] [Related]
14. Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality.
Kashyap A; Wingard J; Cagnoni P; Roy J; Tarantolo S; Hu W; Blume K; Niland J; Palmer JM; Vaughan W; Fernandez H; Champlin R; Forman S; Andersson BS
Biol Blood Marrow Transplant; 2002; 8(9):493-500. PubMed ID: 12374454
[TBL] [Abstract][Full Text] [Related]
15. [A clinical analysis of hepatic veno-occlusive disease after hematopoietic stem cell transplantation].
Qin CJ; Liu LJ; Zhang ZM; Luo L; Lai YR; Li QC
Zhonghua Nei Ke Za Zhi; 2018 Jul; 57(7):483-486. PubMed ID: 29996265
[No Abstract] [Full Text] [Related]
16. Anticoagulant therapy likely increases risk of bleeding in Gynura segetum-induced hepatic sinus obstruction syndrome.
Tan Y; Zhou X
Medicine (Baltimore); 2024 Feb; 103(6):e35914. PubMed ID: 38335400
[TBL] [Abstract][Full Text] [Related]
17. Gynura segetum induces hepatic sinusoidal obstruction syndrome in mice by impairing autophagy.
Zhang H; Jia S; Jin L; Mb JY; Shen Z; Wu J; Yao X; Chen D; Zhang C; Yu S; Zhu N; Jin L; Yao X
Acta Cir Bras; 2022; 36(11):e361104. PubMed ID: 35195181
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease.
Zhuge YZ; Wang Y; Zhang F; Zhu CK; Zhang W; Zhang M; He Q; Yang J; He J; Chen J; Zou XP
Liver Int; 2018 Oct; 38(10):1867-1874. PubMed ID: 29297975
[TBL] [Abstract][Full Text] [Related]
19. Hepatic sinusoidal obstruction syndrome caused by the ingestion of
Cen P; Ding J; Jin J
J Int Med Res; 2021 Apr; 49(4):300060520980649. PubMed ID: 33845617
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment with danhong injection for hepatic veno-occlusive disease.
Yao JY; Zhi M; Cao WT; Huang Y; Li CJ
Hepatogastroenterology; 2011; 58(107-108):992-5. PubMed ID: 21830430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
